Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · Real-Time Price · USD
6.34
+0.13 (2.09%)
At close: Jun 26, 2026, 4:00 PM EDT
6.26
-0.08 (-1.22%)
After-hours: Jun 26, 2026, 7:59 PM EDT
Taysha Gene Therapies Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Taysha Gene Therapies stock have an average target of 12.8, with a low estimate of 9.00 and a high estimate of 19. The average target predicts an increase of 101.89% from the current stock price of 6.34.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Taysha Gene Therapies stock from 13 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 11 | 11 | 11 | 10 | 10 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 14 | 14 | 14 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Keith Tapper CFA BMO Capital | BMO Capital | Buy Maintains $10 → $14 | Buy | Maintains | $10 → $14 | +120.82% | Jun 23, 2026 |
| Citizens JMP | Citizens JMP | Buy Maintains $8 → $11 | Buy | Maintains | $8 → $11 | +73.50% | Jun 23, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $10 | Buy | Reiterates | $10 | +57.73% | Jun 23, 2026 |
Unknown Analyst Jefferies No rating | Jefferies | Buy Maintains $13 | Buy | Maintains | $13 | +105.05% | Jun 23, 2026 |
| Needham | Needham | Buy Reiterates $12 | Buy | Reiterates | $12 | +89.27% | Jun 22, 2026 |
Financial Forecast
Revenue This Year
1.85M
from 9.77M
Decreased by -81.11%
Revenue Next Year
29.70M
from 1.85M
Increased by 1,508.77%
EPS This Year
-0.44
from -0.32
EPS Next Year
-0.44
from -0.44
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 15.0M | 115.7M | |
| Avg | 1.8M | 29.7M | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 53.5% | 6,169.5% | |
| Avg | -81.1% | 1,508.8% | |
| Low | -100.0% | -100.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.36 | -0.37 | |
| Avg | -0.44 | -0.44 | |
| Low | -0.54 | -0.59 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.